Cargando…
Immunotherapy Associated Pulmonary Toxicity: Biology Behind Clinical and Radiological Features
The broader use of immune checkpoint blockade in clinical routine challenges clinicians in the diagnosis and management of side effects which are caused by inflammation generated by the activation of the immune response. Nearly all organs can be affected by immune-related toxicities. However, the mo...
Autores principales: | Porcu, Michele, De Silva, Pushpamali, Solinas, Cinzia, Battaglia, Angelo, Schena, Marina, Scartozzi, Mario, Bron, Dominique, Suri, Jasjit S., Willard-Gallo, Karen, Sangiolo, Dario, Saba, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468855/ https://www.ncbi.nlm.nih.gov/pubmed/30841554 http://dx.doi.org/10.3390/cancers11030305 |
Ejemplares similares
-
The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy
por: Solinas, Cinzia, et al.
Publicado: (2020) -
LAG3: The Biological Processes That Motivate Targeting This Immune Checkpoint Molecule in Human Cancer
por: Solinas, Cinzia, et al.
Publicado: (2019) -
Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression
por: Pellegrino, Benedetta, et al.
Publicado: (2021) -
Cytokine Induced Killer Cells as Promising Immunotherapy for Solid Tumors
por: Sangiolo, Dario
Publicado: (2011) -
Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2022)